Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret Wilsher

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Drugs|June 9, 2017
Erdosteine : A Viewpoint by Margaret WilsherMargaret Wilsher
Respirology (Carlton, Vic.)|August 22, 2018
Managing disease behaviour: A team approachMargaret Wilsher
Chronic Respiratory Disease|November 19, 2010
Review series: Aspects of interstitial lung disease. SarcoidosisSally de Boer, Margaret Wilsher
The New Zealand Medical Journal|May 13, 2003
An uncommon clinical presentation of asbestos-related diseaseChris Walls, Margaret Wilsher, Bill Glass
Thorax|June 5, 2010
Clinical networks for ILD: casting light on diffuse lung shadowsNicholas K Harrison, Norman Johnson, Margaret Wilsher
Respirology (Carlton, Vic.)|September 28, 2011
Prevalence of asthma and atopy in sarcoidosisMargaret Wilsher, Raewyn Hopkins, Irene Zeng, et al.
Respiratory Care|November 19, 2015
Randomized Controlled Trial of Humidified High-Flow Nasal Oxygen for Acute Respiratory Distress in the Emergency Department: The HOT-ER StudyPeter G Jones, Sinan Kamona, Owen Doran, et al.
The European Respiratory Journal|May 3, 2014
Prevalence and prognosis of unclassifiable interstitial lung diseaseLauren Troy, Ian Glaspole, Nicole Goh, et al.
The Medical Journal of Australia|May 3, 2018
Sarcoidosis: a state of the art review from the Thoracic Society of Australia and New ZealandHasib Ahmadzai, Shuying Huang, Chris Steinfort, et al.
Respirology (Carlton, Vic.)|January 20, 2012
The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung diseaseMargaret Wilsher, Nicola Good, Raewyn Hopkins, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drugs|June 9, 2017
Erdosteine : A Viewpoint by Margaret WilsherMargaret Wilsher
Respirology (Carlton, Vic.)|August 22, 2018
Managing disease behaviour: A team approachMargaret Wilsher
Chronic Respiratory Disease|November 19, 2010
Review series: Aspects of interstitial lung disease. SarcoidosisSally de Boer, Margaret Wilsher
The New Zealand Medical Journal|May 13, 2003
An uncommon clinical presentation of asbestos-related diseaseChris Walls, Margaret Wilsher, Bill Glass
Thorax|June 5, 2010
Clinical networks for ILD: casting light on diffuse lung shadowsNicholas K Harrison, Norman Johnson, Margaret Wilsher
Respirology (Carlton, Vic.)|September 28, 2011
Prevalence of asthma and atopy in sarcoidosisMargaret Wilsher, Raewyn Hopkins, Irene Zeng, et al.
Respiratory Care|November 19, 2015
Randomized Controlled Trial of Humidified High-Flow Nasal Oxygen for Acute Respiratory Distress in the Emergency Department: The HOT-ER StudyPeter G Jones, Sinan Kamona, Owen Doran, et al.
The European Respiratory Journal|May 3, 2014
Prevalence and prognosis of unclassifiable interstitial lung diseaseLauren Troy, Ian Glaspole, Nicole Goh, et al.
The Medical Journal of Australia|May 3, 2018
Sarcoidosis: a state of the art review from the Thoracic Society of Australia and New ZealandHasib Ahmadzai, Shuying Huang, Chris Steinfort, et al.
Respirology (Carlton, Vic.)|January 20, 2012
The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung diseaseMargaret Wilsher, Nicola Good, Raewyn Hopkins, et al.
Pageof 2